Castan Chambers, Melbourne, Australia.
University of Melbourne, Melbourne, Australia.
Monash Bioeth Rev. 2021 Dec;39(Suppl 1):4-25. doi: 10.1007/s40592-021-00139-z. Epub 2021 Oct 31.
This article situates the movement for the legalisation of medicinal cannabis within the bigger picture of the impetus toward recreational cannabis legalisation. It describes the role played by children with epileptic syndromes in the medicinal cannabis law reform campaigns in the United Kingdom, and Queensland, New South Wales and Victoria in Australia. Noting the 'rule of rescue' and the prominence in media campaigns of children in Australian and English cases of parental disputation with clinicians about treatment for their children, it reviews whether paediatric epilepsy is a suitable test case for the legalisation of medicinal cannabis. Taking into account the vested commercial interests of Big Cannabis, the current medico-scientific knowledge of the efficacy of medicinal cannabis in controlling paediatric epileptic seizures, and issues of dignity, health privacy, and the enduring digital footprints of media coverage, the article commences discussion about the ethics of the media, parents, politicians and entrepreneurial doctors utilising parents' testimonials about the effects of medicinal cannabis as part of the cannabis law reform movement.
本文将医用大麻合法化运动置于娱乐大麻合法化的大背景下。文中描述了患有癫痫综合征的儿童在英国和澳大利亚昆士兰州、新南威尔士州和维多利亚州的医用大麻法律改革运动中所扮演的角色。文中提到了“救助规则”，以及在澳大利亚和英国的一些案例中，父母与医生就孩子的治疗问题发生争执时，儿童在媒体宣传中的突出地位。文中还探讨了儿科癫痫是否适合作为医用大麻合法化的试点案例。考虑到大型大麻产业的既得商业利益、医用大麻在控制儿童癫痫发作方面的现有医学科学知识，以及尊严、健康隐私以及媒体报道的持久数字足迹等问题，本文开始讨论媒体、家长、政治家和创业医生的伦理问题，即利用家长对医用大麻效果的证明作为大麻法律改革运动的一部分。
